Patent: 10,442,806
✉ Email this page to a colleague
Summary for Patent: 10,442,806
Title: | Substituted heterocycles for targeting HSP90 |
Abstract: | Described herein are substituted indazoles comprising formula (II) that may selectively bind to Hsp90, methods of using the compounds, and kits including the compounds. Formula (II) may link to detection moieties such as fluorophores that may allow for selective detection of Hsp90 in a sample. ##STR00001## |
Inventor(s): | Haystead; Timothy (Chapel Hill, NC), Hughes; Philip Floyd (Chapel Hill, NC), Lascola; Christopher D. (Durham, NC) |
Assignee: | Duke University (Durham, NC) |
Application Number: | 16/000,077 |
Patent Claims: | see list of patent claims |
Details for Patent 10,442,806
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2032-08-06 |
Servier Pharmaceuticals Llc | ONCASPAR | pegaspargase | Injection | 103411 | 02/01/1994 | ⤷ Try a Trial | 2032-08-06 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |